Cargando…

Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study

Introduction: Aim of this retrospective cohort study is to evaluate the prognostic value of tumor volume reduction rate status post-induction chemotherapy in locally advanced head and neck squamous cell carcinoma. Methods: Patients newly diagnosed from year 2007 to 2016 at a single center were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ting-Chun, Huang, Chi-Hsien, Lien, Ming-Yu, Cheng, Fu-Ming, Li, Kai-Chiun, Lin, Chih-Yuan, Lin, Ying-Chun, Liang, Ji-An, Wang, Ti-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252009/ https://www.ncbi.nlm.nih.gov/pubmed/35770906 http://dx.doi.org/10.1177/15330338221107714

Ejemplares similares

Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
por: Su, Yan-Ye, et al.
Publicado: (2016)

Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)
por: Chan, Chien-Yi, et al.
Publicado: (2016)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study
por: Hsieh, Ching-Yun, et al.
Publicado: (2020)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck
por: BAUMAN, JESSICA, et al.
Publicado: (2013)

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
por: Chen, Tsung-Ming, et al.
Publicado: (2022)

Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Chen, Wei-Shan, et al.
Publicado: (2021)

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
por: Thyss, A., et al.
Publicado: (1986)

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Chang, Pei-Hung, et al.
Publicado: (2021)

Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis
por: Ma, Jie, et al.
Publicado: (2013)

Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model
por: Chen, Chi-Yuan, et al.
Publicado: (2009)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

Three therapeutic regimens based on induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: a single center experience
por: Jiang, Lin, et al.
Publicado: (2020)

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma
por: Han, Liang, et al.
Publicado: (2016)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
por: Haddad, R I, et al.
Publicado: (2018)

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
por: Ran, Qiu-Chi, et al.
Publicado: (2021)

Effect of Induction Chemotherapy on Swallowing in Head and Neck Cancer Patients
por: Portas, Juliana, et al.
Publicado: (2019)

The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma
por: Jiang, Wenmei, et al.
Publicado: (2023)

Identification of Prognostic Markers for Head and NeckSquamous Cell Carcinoma Based on Glycolysis-Related Genes
por: Ren, Xiaobin, et al.
Publicado: (2022)

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2022)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
por: Hung, Chuan-Jen, et al.
Publicado: (2022)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023)

Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Modelling tumour volume variations in head and neck cancer: contribution of magnetic resonance imaging for patients undergoing induction chemotherapy
por: Dinapoli, N., et al.
Publicado: (2017)

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
por: Huang, Chuan-En, et al.
Publicado: (2014)

Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation
por: Ock, Chan-Young, et al.
Publicado: (2016)

A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications
por: Chi, Li-Hsing, et al.
Publicado: (2021)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
por: Ferrari, Daris, et al.
Publicado: (2020)

Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
por: Boguszewicz, Łukasz
Publicado: (2022)

Analysis of the Prognostic Factors for Distant Metastasis after Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Head and Neck Cancer
por: Kim, Dong Hyun, et al.
Publicado: (2015)

Construction and Validation of a UPR-Associated Gene Prognostic Model for Head and Neck Squamous Cell Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma
por: Lin, Yu-Hsuan, et al.
Publicado: (2023)

Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck
por: Su, Ying-Wen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ahoa24dkhs7avuee1k3lvrv31m